Summary
The purpose of the study is to the evaluate safety, tolerability, pharmacokinetics (PK),
and efficacy of AZD0466 as monotherapy in partciapants with advanced haematological
malignancies and also to assess drug-drug interaction (DDI) potential between AZD0466 and
the azole antifungal voriconazole.